Insmed (INSM) EBIT (2010 - 2026)
Insmed's EBIT came in at -$1.55 million for Q2 2026, compared with -$312.88 million a year earlier.
Powered by 
Analysis
Insmed (INSM) EBIT (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Insmed reported EBIT of -$840.62 million; for FY2025, it came in at -$1.25 billion.
- Going back by year, EBIT was -$878.25 million in FY2024, -$709.63 million in FY2023, -$457.32 million in FY2022 and -$375.09 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBIT since Q2 2010.
- Business Quant data shows INSM's EBIT at -$153.32 million (Q1 2026), -$319.75 million (Q4 2025) and -$366.01 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Insmed | 25.69 Bn | 20.19 Bn | 358.27 Mn | -1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.55 Mn |
| Mar 31, 2026 | -153.32 Mn |
| Dec 31, 2025 | -319.75 Mn |
| Sep 30, 2025 | -366.01 Mn |
| Jun 30, 2025 | -312.88 Mn |
| Mar 31, 2025 | -248.14 Mn |
| Dec 31, 2024 | -230.41 Mn |
| Sep 30, 2024 | -213.43 Mn |
| Jun 30, 2024 | -288.90 Mn |
| Mar 31, 2024 | -145.51 Mn |
| Dec 31, 2023 | -178.27 Mn |
| Sep 30, 2023 | -147.67 Mn |
| Jun 30, 2023 | -235.53 Mn |
| Mar 31, 2023 | -148.16 Mn |
| Dec 31, 2022 | -151.48 Mn |
| Sep 30, 2022 | -127.70 Mn |
| Jun 30, 2022 | -88.32 Mn |
| Mar 31, 2022 | -89.83 Mn |
| Dec 31, 2021 | -99.08 Mn |
| Sep 30, 2021 | -103.62 Mn |
API Access
Insmed EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();